Top

Published in:

01-08-2010 | Review Article

Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Authors: Roberto De Simone, Angelo Ranieri, Chiara Fiorillo, Leonilda Bilo, Vincenzo Bonavita

Published in: Neurological Sciences | Issue 4/2010

Abstract

The association of chronic migraine (CM) with an idiopathic intracranial hypertension without papilledema (IIHWOP), although much more prevalent than expected in clinical series of CM sufferers, is not included among the risk factors for migraine progression. We discuss the available evidence supporting the existence of a pathogenetic link between CM and idiopathic intracranial hypertensive disorders and suggest a causative role for IIHWOP in migraine progression.

Bigal ME, Lipton RB (2008) Concepts and mechanisms of migraine chronification. Headache 48:7–15PubMedCrossRef

Bigal ME, Lipton RB (2008) Clinical course in migraine conceptualizing migraine transformation. Neurology 71:848–855CrossRefPubMed

Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27:102–106CrossRefPubMed

Mathew NT (1993) Transformed migraine. Cephalalgia 13:78–83PubMed

Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset remission of chronic daily headache in a population-based study. Pain 106:81–89CrossRefPubMed

Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2005) Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 65:1556–1561CrossRefPubMed

Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 (Suppl 1):9–160

Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB (2004) Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 44:684–691CrossRefPubMed

Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746CrossRef

10.

Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2007) The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia 27:230–234CrossRef

11.

Sancisi E, Cevoli S, Pierangeli G, Zanigni S, Grimaldi D, Nicodemo M, Cortelli P, Montagna P (2007) Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache. Neurol Sci 28:2–8CrossRefPubMed

12.

D’Amico D, Tullo V, Proietti Cecchini A, Usai S, Mea E, Bussone G (2008) Application of revised criteria for chronic migraine and medication overuse headache in a tertiary headache centre. Neurol Sci 29:S158–S160CrossRefPubMed

13.

Siberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 34:1–7PubMed

14.

Scher AI, Stewart WF, Liberman J, Lipton RB (1998) Prevalence of frequent headache in a population sample. Headache 38:497–506CrossRefPubMed

15.

Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s classification of functioning, disability and health (ICF). J Headache Pain 6:429–440CrossRefPubMed

16.

Edmeads J, Mackell JA (2002) The economic impact of migraine: an analysis of direct and indirect costs. Headache 42:501–509CrossRefPubMed

17.

Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J et al (2009) Economic burden of transformed migraine: results from the American migraine prevalence and prevention (AMPP) study. Headache 49:498–508CrossRefPubMed

18.

Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G et al (2008) Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache 48:1087–1095CrossRefPubMed

19.

Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269–276CrossRefPubMed

20.

Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 66:1894–1898CrossRefPubMed

21.

Zeeberg P, Olesen J, Jensen R (2006) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26:1192–1198CrossRefPubMed

22.

Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179–190CrossRefPubMed

23.

Castillo J, Munoz P, Guitera V, Pascual J (1999) Kaplan Award 1998: epidemiology of chronic daily headache in the general population. Headache 39:190–196CrossRefPubMed

24.

Colás R, Muñoz P, Temprano R, Gómez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338–1342PubMed

25.

Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871–875PubMed

26.

Obermann M, Nyhuis P et al (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26:1106–1114CrossRefPubMed

27.

Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495CrossRefPubMed

28.

Lipton HL, Michelson PE (1972) Pseudotumor cerebri syndrome without papilledema. J Am Med Assoc 220:1591–1592CrossRef

29.

Marcelis J, Silberstein SD (1992) Idiopathic intracranial hypertension without papilledema. Arch Neurol 48:392–399

30.

Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424PubMed

31.

King JO, Mitchell PJ, Thomson KR, Tress BM (2002) Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 58:26–30PubMed

32.

Karakalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198–202

33.

De Simone R, Marano E, Fiorillo C, Briganti F, Di Salle F, Volpe A, Bonavita V (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension: pathogenetic implications. Neurol Sci 25:342–344CrossRefPubMed

34.

Higgins JNP, Pickard JD (2004) Lateral sinus stenosis in idiopathic intracranial hypertension resolving after CSF diversion. Neurology 62:1907–1908PubMed

35.

Baryshnik DB, Farb RI (2004) Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 62:1445–1446PubMed

36.

Rohr A, Dörner L, Stingele R, Buhl R, Alfke K, Jansen O (2007) Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 28:656PubMed

37.

Brazis PW (2008) Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 28:1361–1373CrossRefPubMed

38.

Stevens SA, Lakin W, Thakore N, Penar PL, Tranmer B (2005) A modeling study of idiopathic intracranial hypertension. In: Ursino M (ed) Modelling in medicine and biology VI, WIT Press, Southampton

39.

Stevens SA, Stimpson J, Lakin WD, Thakore NJ, Penar PL (2008) A model for idiopathic intracranial hypertension and associated pathological ICP wave-forms. IEEE Trans Biomed Eng 55(2 Pt 1):388–398CrossRefPubMed

40.

Bono F, Giliberto C, Mastrandrea C, Cristiano D, Lavano A, Fera F, Quattrone A (2005) Transverse sinus stenosis persist after normalization of the CSF pressure in IIH. Neurology 65:1090–1093CrossRefPubMed

41.

Torbey MT, Geocadin RG, Razumovsky AY, Rigamonti D, Williams MA (2003) Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia 24:495–502CrossRef

42.

Bono F, Messina D, Giliberto C, Cristiano D, Broussard G, D’Asero S, Condino F, Mangone L, Mastrandrea C, Fera F, Quattrone A (2008) Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol 255(6):807–812CrossRefPubMed

43.

Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46:1226–1230PubMed

44.

Wang SJ, Silberstein SD, Patterson S, Young WB (1998) Idiopathic intracranial hypertension without papilledema: a case–control study in a headache center. Neurology 51(1):245–249PubMed

45.

Vieira DS, Masruha MR, Gonçalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G, Peres MF (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28:609–613CrossRefPubMed

46.

Bono F, Quattrone A (2009) Idiopathic intracranial hypertension without papilloedema in headache sufferers. Cephalalgia 29(5):593 (author reply 594)

47.

Bono F, Messina D, Giliberto C, Cristiano D, Broussard G, Fera F et al (2006) Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67:419–423CrossRefPubMed

48.

Wall M (2008) Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 8:87–93CrossRefPubMed

49.

Marcus DM, Lynn J, Miller JJ, Chaudhary O, Thomas D, Chaudhary B (2001) Sleep disorders: a risk factor for pseudotumor cerebri? J Neuroophthalmol 21:121–123PubMed

50.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ et al (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814–823CrossRefPubMed

51.

Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29:1021–1027CrossRefPubMed

52.

Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(Suppl 1):S35–S39CrossRefPubMed

53.

Johnson LN, Krohel GB, Madsen RW, March GA Jr (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105:2313–2317CrossRefPubMed

54.

Pagan FL, Restrepo L, Balish M, Patwa HS, Houff S (2002) A new drug for an old condition. Headache 42:695–696CrossRefPubMed

55.

Palacio E, Rodero L, Pascual J (2004) Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome. Headache 44:436–437CrossRefPubMed

56.

Celebisoy N, Gökçay F, Sirin H, Akyürekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327CrossRefPubMed

57.

De Simone R, Marano E, Bilo L, Briganti F, Esposito M, Ripa P et al (2006) Idiopathic intracranial hypertension without headache. Cephalalgia 26:1020–1021CrossRefPubMed

58.

Bonavita V, De Simone R (2008) Towards a definition of comorbidity in the light of clinical complexity. Neurol Sci 29(Suppl 1):S99–S102CrossRefPubMed

59.

Doepp F, Schreiber SJ, Dreier JP, Einhäupl KM, Valdueza JM (2003) Migraine aggravation caused by cephalic venous congestion. Headache 43:96–98CrossRefPubMed

60.

Chou CH, Chao AC, Lu SR, Hu HH, Wang SJ (2004) Cephalic venous congestion aggravates only migraine-type headaches. Cephalalgia 24:973–979CrossRefPubMed

Title: Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?
Authors: Roberto De Simone
Angelo Ranieri
Chiara Fiorillo
Leonilda Bilo
Vincenzo Bonavita
Publication date: 01-08-2010
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 4/2010
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-010-0229-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Psychosocial issue in children and adolescents with multiple sclerosis

S.F. Cappa, J. Abutalebi, J.-F. Demonet, P.C. Fletcher, P. Garrard (eds): Cognitive neurology—a clinical textbook

Brain damage and semantic category dissociations: is the animals category easier for males?

Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis

Ataxia with vitamin E deficiency: update of molecular diagnosis

Cognitive dysfunction in a patient with brainstem hemorrhage